|
|
|
| Heparin-free Dialysis and Filtration in the treatment of 60 cases of Uremia Complicated with Upper Gastrointestinal Bleeding |
| DENG Cheng'ai, LU Lihua, WU Qi |
| The First People's Hospital of Zhaotong, Yunnan Zhaotong 657000, China |
|
|
|
|
Abstract Objective: To observe the curative effect of heparin-free hemodiafiltration on uremia with upper gastrointestinal bleeding. Methods: 120 patients with uremia complicated with upper gastrointestinal bleeding in our hospital from January 2013 to January 2017 were randomly divided into two groups, 60 cases in each group. Group A was treated with local citrate anticoagulant hemodialysis, and group B was treated with heparin-free hemodiafiltration. The activated partial thromboplastin time (APTT), activated clotting time (ACT), pH of gastric juice, blood biochemical indicators and blood gas analysis before and after dialysis were compared between the two groups. The occurrence of dialyzer and tube coagulation in both groups was observed. Results: After dialysis, the APTT and ACT in group B were significantly shorter than those in group A (P<0.05), and the pH of gastric juice was significantly higher than that in group A (P<0.05). The levels of BUN and SCr in group B were significantly lower than those in group A (P<0.05). There were no significant differences in the level of Ca2+ or K+ or blood pH between the two groups (P>0.05). The HCO3- levels in group B were significantly lower than those in group A (P<0.05). There was no significant difference in the incidence of coagulation between group A and group B (10.00% vs 13.33%) (P>0.05). Conclusion: Heparin-free hemodiafiltration for uremia with upper gastrointestinal bleeding can effectively improve the renal function and pH of gastric juice, and correct potassium abnormalities. Local citrate anticoagulant hemodialysis is superior to heparin-free dialysis in terms of extracorporeal circulation.
|
|
|
|
|
|
[1] Adamson J W,Akizawa T,Anker S D,et al.Iron management in chronic kidney disease:conclusions from a"kidney disease:improving global outcomes"(KDIGO) controversies conference[J].Kidney International,2016,89(1):28~39.
[2] 苏彬,娄丽华,刘莉,等.维持性血液透析患者并发消化道出血的危险因素及防治对策[J].河北医学,2017,23(11):1862~1864.
[3] Lin C C,Hsu Y L,Chung C S,et al.Stress ulcer prophylaxis in patients being weaned from the ventilator in a respiratory care center:a randomized control trial[J].Journal of the Formosan Medical Association,2016,115(1):19~24.
[4] Gonzalez J,Bryant S,Hermesdesantis E R.Transdermal estradiol for the management of refractory uremic bleeding.[J].American Journal of Health-System Pharmacy,2018,75(9):e177~e183.
[5] Islam M S,Hassan Z A,Chalmin F,et al.Vitamin e-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis:a multicenter,randomized,crossover Trial[J].American Journal of Kidney Diseases,2016,68(5):752~762.
[6] 叶任高.内科学[M].第5版.北京:人民卫生出版社,2001.319.
[7] 曾继兰,刘泽英.维持性血液透析患者并发消化道出血的护理干预效果观察[J].现代消化及介入诊疗,2017,22(5):746~748.
[8] 朱俊,赵学智.VHL综合征双肾切除术后维持性血液透析并发上消化道出血1例[J].临床肾脏病杂志,2016,16(2):128.
[9] 郑颖来.尿毒症伴出血倾向患者于无肝素血液透析期间凝血功能变化[J].血栓与止血学,2018,24(1):170~172.
[10] 朱亭立,张渊,尤金芳,等.不同冲洗速度对无肝素血液透析患者的影响[J].护理学杂志,2016,31(21):35~37.
[11] 李敏.无肝素透析在活动性出血老年尿毒症治疗中的应用[J].国际老年医学杂志,2016,37(1):32~33. |
|
|
|
2019, Vol. 25 
